Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multi-center open-label uncontrolled study in patients with ventricular arrhythmia

Next Previous
Trial Profile

A multi-center open-label uncontrolled study in patients with ventricular arrhythmia

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 07 Dec 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Landiolol (Primary)
  • Indications Ventricular arrhythmias
  • Focus Registrational; Therapeutic Use
  • Sponsors Ono Pharmaceutical

    • Most Recent Events

    • 23 May 2019 Primary endpoint of proportion of patients free from recurrent hemodynamically unstable VT or the proportion of patients free from recurrent VF has been met according to results published in the Circulation Journal.
    • 23 May 2019 Results published in the Circulation Journal
    • 26 Mar 2019 According to an Ono Pharmaceutical media release, based on the results of this study, the company received an approval for ONOACT (landiolol hydrochloride) for intravenous infusion (50mg/150mg) for indication of ventricular arrhythmia as a partial change in the approved items of the manufacturing and marketing approval in Japan.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top